Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The growth was driven by strong demand for new medicines, which offset ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...

In addition, rents saw healthy growth in the fourth quarter, increasing 1.8 percent year-over-year. However, the rate is ...

We believe VF is in decent financial shape despite a high amount of debt. At the end of fiscal 2024, the firm had about $6 billion in total debt and $675 million in cash; its net debt/adjusted EBITDA ...

Discover Tractor Supply Company's strategic growth plans and latest earnings results in this insightful financial article.

The legal U.S. legal cannabis industry recorded its 11th consecutive year of growth in 2024, though the pace of expansion ...

Eaton Corporation (NYSE:ETN) shares are trading lower on Friday after the company reported fourth-quarter 2024 results.

Shares of retail chain Boot Barn ( BOOT -8.28%) dropped on Friday after the company reported financial results for its fiscal ...

President Donald Trump signed a flurry of executive orders during his first week in office, giving the impression that he took sweeping action on many of his campaign promises. But as critics have ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

China could be leading the charge, but the US, Canada, and Europe won’t be far behind.

CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...